These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 38537873

  • 1. Sleep and local field potential effect of the D2 receptor agonist bromocriptine during the estrus cycle and postpartum period in female rats.
    Tóth A, Keserű D, Pethő M, Détári L, Bencsik N, Dobolyi Á, Hajnik T.
    Pharmacol Biochem Behav; 2024 Jun; 239():173754. PubMed ID: 38537873
    [Abstract] [Full Text] [Related]

  • 2. Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats.
    Moro M, Inada Y, Miyata H, Komatsu H, Kojima M, Tsujii H.
    Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):651-8. PubMed ID: 11473532
    [Abstract] [Full Text] [Related]

  • 3. The effects of bromocriptine treatment during early pregnancy on postpartum maternal behaviors in rats.
    Price AK, Bridges RS.
    Dev Psychobiol; 2014 Sep; 56(6):1431-7. PubMed ID: 24889499
    [Abstract] [Full Text] [Related]

  • 4. The effects of local microinjection of selective dopamine D1 and D2 receptor agonists and antagonists into the dorsal raphe nucleus on sleep and wakefulness in the rat.
    Monti JM, Jantos H.
    Behav Brain Res; 2018 Feb 26; 339():11-18. PubMed ID: 29137945
    [Abstract] [Full Text] [Related]

  • 5. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
    Giacomelli S, Palmery M, Romanelli L, Cheng CY, Silvestrini B.
    Life Sci; 1998 Feb 26; 63(3):215-22. PubMed ID: 9698051
    [Abstract] [Full Text] [Related]

  • 6. Bromocriptine-induced blockade of pregnancy affects sleep patterns in rats.
    Zhang SQ, Kimura M, Inoué S.
    Neuroimmunomodulation; 1996 Feb 26; 3(4):219-26. PubMed ID: 9094443
    [Abstract] [Full Text] [Related]

  • 7. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
    Ishida M, Mitsui T, Izawa M, Arita J.
    Mol Cell Endocrinol; 2013 Aug 15; 375(1-2):58-67. PubMed ID: 23701824
    [Abstract] [Full Text] [Related]

  • 8. Complete sleep and local field potential analysis regarding estrus cycle, pregnancy, postpartum and post-weaning periods and homeostatic sleep regulation in female rats.
    Tóth A, Pethő M, Keserű D, Simon D, Hajnik T, Détári L, Dobolyi Á.
    Sci Rep; 2020 May 22; 10(1):8546. PubMed ID: 32444809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
    Bonnin A, Ramos JA, Rodríguez de Fonseca F, Cebeira M, Fernández-Ruiz JJ.
    Neuroendocrinology; 1993 Sep 22; 58(3):280-6. PubMed ID: 7902959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P, Scorza C, Monti JM, Jantos H, Reyes-Parada M, Silveira R, Ponzoni A.
    Eur Neuropsychopharmacol; 1998 May 22; 8(2):113-20. PubMed ID: 9619689
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape.
    Arita J, Hashi A, Hoshi K, Mazawa S, Suzuki S.
    Neuroendocrinology; 1998 Sep 22; 68(3):163-71. PubMed ID: 9734000
    [Abstract] [Full Text] [Related]

  • 20. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J, Chevallier P, Remy C, Rajas F, Cohen R, Calle A, Hooghe-Peters EL, Rousset B.
    Endocrinology; 1999 Jan 22; 140(1):13-21. PubMed ID: 9886801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.